Supplementary Data S1-S9 from Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial

Data S1 shows the gene content of the 770 gene panel, Data S2-S3 show the expression scores for different gene and metagenes, Data S4-S7 show univariate analyses for different genes and metagenes according to treatment arm, Data S8-S9 show functional annotation and enrichment analysis for genes associated with capecitabine benefit